• wonderlic tests
  • EXAM REVIEW
  • NCCCO Examination
  • Summary
  • Class notes
  • QUESTIONS & ANSWERS
  • NCLEX EXAM
  • Exam (elaborations)
  • Study guide
  • Latest nclex materials
  • HESI EXAMS
  • EXAMS AND CERTIFICATIONS
  • HESI ENTRANCE EXAM
  • ATI EXAM
  • NR AND NUR Exams
  • Gizmos
  • PORTAGE LEARNING
  • Ihuman Case Study
  • LETRS
  • NURS EXAM
  • NSG Exam
  • Testbanks
  • Vsim
  • Latest WGU
  • AQA PAPERS AND MARK SCHEME
  • DMV
  • WGU EXAM
  • exam bundles
  • Study Material
  • Study Notes
  • Test Prep

NURS 615 PHARMACOLOGY EXAM QNS AND ANS 2026/2027 (27pages)

NURS EXAM Mar 26, 2024
Preview Mode - Purchase to view full document
Loading...

Loading study material viewer...

Page 0 of 0

Document Text

started: 1 . Loratadine 2 . Diphenhydramine 3 . Ipratropium 4 . Albuterol Albuterol 2. Patients with pheochromocytoma should avoid which of the following classes of drugs because of the possibility of developing hypertensive crisis? 1 . Expectorants 2 . Beta-2-agonists 3 . Antitussives 4 . Antihistamines Beta 2-agonists 3. Stan, a 42-year-old African American, has moderate persistent asthma. Which of the following asthma medications should be used cautiously, if at all? 1 . Betamethasone, an inhaled corticosteroid 2 . Salmeterol, an inhaled long-acting beta-agonist 3 . Albuterol, a short-acting beta-agonist 4 . Montelukast, a leukotriene modifier Salmeterol, an inhaled long-acting beta-agonist 4. Long-acting beta-agonists (LTBAs) received a Black Box Warning from the U.S. Food and Drug Administration due to the: 1 . Risk of life-threatening dermatological reactions 2 Increased incidence of cardiac events when LTBAs are used


Download Study Material

Buy This Study Material

$14.00
Buy Now
  • Immediate download after payment
  • Available in the pdf format
  • 100% satisfaction guarantee

Study Material Information

Category: NURS EXAM
Description:

NURS 615 PHARMACOLOGY EXAM QNS AND ANS 2026/2027 (27pages)

UNLOCK ACCESS $14.00